Pfizer Pushes To Toss More Cases From Bextra MDL

Law360, New York (December 11, 2007, 12:00 AM EST) -- As it prepares its defense for the coming bellwether trials over its anti-inflammatory drugs, pharmaceutical giant Pfizer Inc. continues its campaign to toss cases from the multidistrict litigation.

The drug maker has urged the U.S. District Court for the Northern District of California to summarily boot 61 cases from the action over Bextra and Celebrex, arguing that the plaintiffs disregarded pretrial orders and ignored the company's recent motion for dismissal.

Pfizer, along with co-defendants Pharmacia Corp. and G.D. Searler LLC, said in a joint brief filed...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.